Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Higher circulating levels of the branched-chain amino acids (BCAAs; i.e., isoleucine, leucine, and valine) are strongly associated with higher type 2 diabetes risk, but it is not known whether this association is causal. We undertook large-scale human genetic analyses to address this question. METHODS AND FINDINGS: Genome-wide studies of BCAA levels in 16,596 individuals revealed five genomic regions associated at genome-wide levels of significance (p < 5 × 10-8). The strongest signal was 21 kb upstream of the PPM1K gene (beta in standard deviations [SDs] of leucine per allele = 0.08, p = 3.9 × 10-25), encoding an activator of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) responsible for the rate-limiting step in BCAA catabolism. In another analysis, in up to 47,877 cases of type 2 diabetes and 267,694 controls, a genetically predicted difference of 1 SD in amino acid level was associated with an odds ratio for type 2 diabetes of 1.44 (95% CI 1.26-1.65, p = 9.5 × 10-8) for isoleucine, 1.85 (95% CI 1.41-2.42, p = 7.3 × 10-6) for leucine, and 1.54 (95% CI 1.28-1.84, p = 4.2 × 10-6) for valine. Estimates were highly consistent with those from prospective observational studies of the association between BCAA levels and incident type 2 diabetes in a meta-analysis of 1,992 cases and 4,319 non-cases. Metabolome-wide association analyses of BCAA-raising alleles revealed high specificity to the BCAA pathway and an accumulation of metabolites upstream of branched-chain alpha-ketoacid oxidation, consistent with reduced BCKD activity. Limitations of this study are that, while the association of genetic variants appeared highly specific, the possibility of pleiotropic associations cannot be entirely excluded. Similar to other complex phenotypes, genetic scores used in the study captured a limited proportion of the heritability in BCAA levels. Therefore, it is possible that only some of the mechanisms that increase BCAA levels or affect BCAA metabolism are implicated in type 2 diabetes. CONCLUSIONS: Evidence from this large-scale human genetic and metabolomic study is consistent with a causal role of BCAA metabolism in the aetiology of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, increased SCFA consumption may alleviate the hyperglycemic responses that are occurring in obese and type 2 diabetics, characterized by elevated amino-acid concentrations [154].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Self-citationDavey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Self-citationAn atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255
Self-citationGut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Mendelian Randomization: Concepts and Scope
Richmond, R. C., & Davey Smith, G. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a040501 · Cited by 841
Neinast, M., Murashige, D., & Arany, Z. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114455 · Cited by 714
Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
Holmes, M. V., Ala-Korpela, M., & Smith, G. D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.78 · Cited by 679
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 663
Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics
Morigny, P., Boucher, J., Arner, P., & Langin, D. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00471-8 · Cited by 527
Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids
Neinast, M. D., Jang, C., Hui, S., Murashige, D. S., Chu, Q., Morscher, R. J., Li, X., Zhan, L., White, E., Anthony, T. G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.013 · Cited by 496
“Most recently, a human Mendelian randomization study demonstrated that polymorphisms that cause elevations in BCAAs also predict insulin resistance (Lotta et al., 2016).”
BackgroundPrecision Nutrition and the Microbiome, Part I: Current State of the Science
Mills, S., Stanton, C., Lane, J., Smith, G., & Ross, R. (2019) · Nutrients · doi:10.3390/nu11040923 · Cited by 399
“A causal role of BCAA metabolism in the aetiology of type 2 diabetes was reported following a large-scale human genetic and metabolomic study [276].”
BackgroundThe adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine
Yu, D., Richardson, N. E., Green, C. L., Spicer, A. B., Murphy, M. E., Flores, V., Jang, C., Kasza, I., Nikodemova, M., Wakai, M. H., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.025 · Cited by 391
“…have long been implicated in the etiology of type 2 diabetes; blood levels of BCAAs are positively correlated with insulin resistance, obesity, and diabetes in both humans and rodents (Batch et al., 2013; Connelly et al., 2017; Felig et al., 1969; Lotta et al., 2016; Newgard et al., 2009).”
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Ren, J., Wu, N. N., Wang, S., Sowers, J. R., & Zhang, Y. (2021) · Physiological Reviews · doi:10.1152/physrev.00030.2020 · Cited by 370
White, P. J., McGarrah, R. W., Grimsrud, P. A., Tso, S.-C., Yang, W.-H., Haldeman, J. M., Grenier-Larouche, T., An, J., Lapworth, A. L., Astapova, I., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.015 · Cited by 365
“Thus, on the one hand, these studies show that genetic variants that cause insulin resistance and dyslipidemia in human populations are strongly associated with increased circulating BCAA, but variants that directly raise BCAA do not exhibit ‘‘reverse causality’’ with insulin resistance (Lotta et al., 2016; Mahendran…”
Multi-omics integration in biomedical research – A metabolomics-centric review
Wörheide, M. A., Krumsiek, J., Kastenmüller, G., & Arnold, M. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.10.038 · Cited by 334
“[1] using a Mendelian Randomization approach, were consistent with a causal role of BCAA metabolism in type 2 diabetes and suggested the PPM1K gene (genetic variants therein being specifically associated with levels of BCAA in blood) as a potential drug target.”
BackgroundMethodMorze, J., Wittenbecher, C., Schwingshackl, L., Danielewicz, A., Rynkiewicz, A., Hu, F. B., & Guasch-Ferré, M. (2022) · Diabetes Care · doi:10.2337/dc21-1705 · Cited by 298
“BCAAs were the first and, so far, the most widely investigated group of metabolites in the context of type 2 diabetes development (27,65).”
BackgroundBranched-chain amino acids in disease
White, P. J., & Newgard, C. B. (2019) · Science · doi:10.1126/science.aav0558 · Cited by 302
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Petucci, C., Kim, M.-S., Bedi, K. C., Wang, H., Mishra, S., Koleini, N., Yoo, E. J., Margulies, K. B., Arany, Z., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061846 · Cited by 294
Vanweert, F., Schrauwen, P., & Phielix, E. (2022) · Nutrition & Diabetes · doi:10.1038/s41387-022-00213-3 · Cited by 289
“Indeed, gene expression studies revealed downregulation in multiple steps of the BCAA catabolic pathway in skeletal muscle of individuals with insulin resistance [25, 129] and patients with T2D [62].”
BackgroundResultInfluentialInsulin action, type 2 diabetes, and branched-chain amino acids: A two-way street
White, P. J., McGarrah, R. W., Herman, M. A., Bain, J. R., Shah, S. H., & Newgard, C. B. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101261 · Cited by 287
Advancing the use of genome-wide association studies for drug repurposing
Reay, W. R., & Cairns, M. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00387-z · Cited by 283
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
Tynkkynen, J., Chouraki, V., van der Lee, S. J., Hernesniemi, J., Yang, Q., Li, S., Beiser, A., Larson, M. G., Sääksjärvi, K., Shipley, M. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.01.003 · Cited by 272
“A Mendelian randomization study on BCAAs and risk of type 2 diabetes has been published suggesting that suitable single-nucleotide polymorphisms exist [49], although this work has been recently criticized for the possibility of misinterpretation due to pleiotropism [50].”
BackgroundDimou, A., Tsimihodimos, V., & Bairaktari, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074022 · Cited by 253
“Moreover, a common variant rs1440581 near the PPM1K gene was found to be associated with high plasma BCAAs, less weight loss in response to dietary interventions [52], decreased insulin sensitivity and T2DM [53,54] (Figure 5).”
BackgroundConnection Between BMI-Related Plasma Metabolite Profile and Gut Microbiota
Ottosson, F., Brunkwall, L., Ericson, U., Nilsson, P. M., Almgren, P., Fernandez, C., Melander, O., & Orho-Melander, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02114 · Cited by 245
“In particular, branchedchain and aromatic amino acids (BCAAs) have been suggested to be of etiological importance, with prospective studies showing them to predict for both future diabetes (4, 5) and cardiovascular disease (6–8) in several cohorts.”
BackgroundDiabetes and branched‐chain amino acids: What is the link?: 糖尿病与支链氨基酸:有什么关联吗?
Bloomgarden, Z. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12645 · Cited by 229
An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study
Yuan, S., & Larsson, S. C. (2020) · Diabetologia · doi:10.1007/s00125-020-05253-x · Cited by 229
The Potential of Metabolomics in Biomedical Applications
Gonzalez-Covarrubias, V., Martínez-Martínez, E., & del Bosque-Plata, L. (2022) · Metabolites · doi:10.3390/metabo12020194 · Cited by 227
Biomarkers for type 2 diabetes
Laakso, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.016 · Cited by 225
“In a GWAS of BCAAs the strongest signal was for leucine, encoding an activator of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) responsible for the ratelimiting step in BCAA catabolism [60].”
BackgroundTobias, D. K., Lawler, P. R., Harada, P. H., Demler, O. V., Ridker, P. M., Manson, J. E., Cheng, S., & Mora, S. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.118.002157 · Cited by 219
Branched-chain amino acids and brain metabolism
Sperringer, J. E., Addington, A., & Hutson, S. M. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2261-5 · Cited by 218
Ahola-Olli, A. V., Mustelin, L., Kalimeri, M., Kettunen, J., Jokelainen, J., Auvinen, J., Puukka, K., Havulinna, A. S., Lehtimäki, T., Kähönen, M., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05001-w · Cited by 214
Metabolomics and Proteomics in Type 2 Diabetes
Chen, Z.-Z., & Gerszten, R. E. (2020) · Circulation Research · doi:10.1161/circresaha.120.315898 · Cited by 204
A cross-platform approach identifies genetic regulators of human metabolism and health
MacTel Consortium, Lotta, L. A., Pietzner, M., Stewart, I. D., Wittemans, L. B. L., Li, C., Bonelli, R., Raffler, J., Biggs, E. K., Oliver-Williams, C., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00751-5 · Cited by 200
“The levels of 174 metabolites were measured in the Fenland study by the AbsoluteIDQ® Biocrates p180 Kit (Biocrates Life Sciences AG, Innsbruck, Austria) as reported elsewhere in detail 39,40 .”
Self-citationImplication of gut microbiota metabolites in cardiovascular and metabolic diseases
Brial, F., Le Lay, A., Dumas, M.-E., & Gauguier, D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2901-1 · Cited by 198
Interorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jelenik, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 192
Vangipurapu, J., Stancáková, A., Smith, U., Kuusisto, J., & Laakso, M. (2019) · Diabetes · doi:10.2337/db18-1076 · Cited by 185
“Several metabolites, including especially branched chain and aromatic amino acids (AAs), have been reported to be associated with the risk of type 2 diabetes in previous studies (2-5).”
BackgroundWang, Q., Holmes, M. V., Davey Smith, G., & Ala-Korpela, M. (2017) · Diabetes Care · doi:10.2337/dc17-1642 · Cited by 182
“Thus, elevated circulating BCAA levels observed in obese and diabetic individuals could arise from impaired BCAA catabolism (11).”
BackgroundInfluentialBranched Chain Amino Acids in Metabolic Disease
Arany, Z., & Neinast, M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1048-7 · Cited by 182
Genetic predictors of participation in optional components of UK Biobank
Tyrrell, J., Zheng, J., Beaumont, R., Hinton, K., Richardson, T. G., Wood, A. R., Davey Smith, G., Frayling, T. M., & Tilling, K. (2021) · Nature Communications · doi:10.1038/s41467-021-21073-y · Cited by 162
Pietzner, M., Kaul, A., Henning, A., Kastenmüller, G., Artati, A., Lerch, M. M., Adamski, J., Nauck, M. A., & Friedrich, N. (2017) · BMC Medicine · doi:10.1186/s12916-017-0974-6 · Cited by 157
Genomic insights into the causes of type 2 diabetes
Langenberg, C., & Lotta, L. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31132-2 · Cited by 176
Self-citationMundra, P. A., Barlow, C. K., Nestel, P. J., Barnes, E. H., Kirby, A. C., Thompson, P. L., SULLIVAN, D. R., Alshehry, Z. H., Mellett, N. A., Huynh, K., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121326 · Cited by 151
“Mendelian randomization studies have identified PPM1K , an activator of branched-chain α -ketoacid dehydrogenase (BCKD), a key enzyme in branched-chain amino acid catabolism, as associated with both branched-chain amino acid levels and incident T2D (26).”
BackgroundInfluentialAmino Acid Sensing in Metabolic Homeostasis and Health
Hu, X., & Guo, F. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa026 · Cited by 149
Ruiz‐Canela, M., Guasch‐Ferré, M., Toledo, E., Clish, C. B., Razquín, C., Liang, L., Wang, D. D., Corella, D., Estruch, R., Hernáez, Á., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4611-5 · Cited by 148
“Mendelian randomisation analyses have suggested both the causal role of BCAA metabolism in the aetiology of type 2 diabetes [25] but also that higher BCAA levels are not likely to be a cause, but rather a consequence, of insulin resistance [28].”
Libert, D. M., Nowacki, A. S., & Natowicz, M. R. (2018) · PeerJ · doi:10.7717/peerj.5410 · Cited by 147
“Accelerated protein breakdown, a consequence of insulin resistance, may also explain in part the increased levels of BCAAs in persons with diabetes or obesity (Lotta et al., 2016).”
BackgroundAssessing the causal association of glycine with risk of cardio-metabolic diseases
Wittemans, L. B. L., Lotta, L. A., Oliver‐Williams, C., Stewart, I. D., Surendran, P., Karthikeyan, S., Day, F. R., Koulman, A., Imamura, F., Zeng, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08936-1 · Cited by 150
Self-citationXu, Y., Jiang, H., Li, L., Chen, F., Liu, Y., Zhou, M., Wang, J., Jiang, J., Li, X., Fan, X., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043581 · Cited by 135
Biswas, D., Duffley, L., & Pulinilkunnil, T. (2019) · The FASEB Journal · doi:10.1096/fj.201802842rr · Cited by 132
“Notably, genome-wide association studies identified a common variant rs1440581 near the PPM1K gene associated with high circulating BCAAs (160) and causally linked to weight loss, insulin sensitivity, and T2D (4, 160–162).”
BackgroundAnimal and Plant Protein Sources and Cardiometabolic Health
Mariotti, F. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy110 · Cited by 156
“Recent Mendelian randomization analyses suggested a causal role of BCAA metabolism, which is impaired by insulin resistance, in the etiology of type 2 diabetes (166, 168, 169).”
BackgroundZhao, X., Jiang, Y., Xi, H., Chen, L., & Feng, X. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1081-2036 · Cited by 124
“Zheng et al. [47] found in three prospective cohort studies that the more BCAAs people ingested, the more likely they were to develop type 2 diabetes [48].”
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 140
Systems biology in hepatology: approaches and applications
Mardinoğlu, A., Borén, J., Smith, U., Uhlén, M., & Nielsen, J. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0007-8 · Cited by 134
Regulation of maternal–fetal metabolic communication
Bowman, C. E., Arany, Z. P., & Wolfgang, M. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03674-w · Cited by 143
Bragg, F., Trichia, E., Aguilar-Ramirez, D. J., Bešević, J., Lewington, S., & Emberson, J. (2022) · BMC Medicine · doi:10.1186/s12916-022-02354-9 · Cited by 127
“More specifically, genetic association studies have shown increased BCAA levels as a consequence of insulin resistance [32], which, in turn, appear to be causally related to T2D [33].”
BackgroundWelsh, P. I., Rankin, N., Li, Q., Mark, P. B., Würtz, P., Ala‐Korpela, M., Marre, M., Poulter, N. R., Hamet, P., Chalmers, J. P., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4619-x · Cited by 124
“The causal pathway may not be unidirectional; a recent Mendelian randomisation study suggests that genetically elevated BCAAs (via impaired catabolism) are associated with increased risk of type 2 diabetes [34], although a better understanding of the underlying pathway is required to increase confidence in this observ…”
BackgroundPirro, V., Roth, K. D. W., Lin, Y., Willency, J. A., Milligan, P. L., Wilson, J. M., Ruotolo, G., Haupt, A., Newgard, C. B., & Duffin, K. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab722 · Cited by 125
Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis
Yarmolinsky, J., Bonilla, C., Haycock, P., Langdon, R., Lotta, L. A., Langenberg, C., Relton, C. L., Lewis, S. J., Evans, D. M., Smith, G. D., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy081 · Cited by 116
“Methods for this meta-analysis have been published previously (13).”
MethodSelf-citationPro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis
May-Wilson, S., Sud, A., Law, P., Palin, K., Tuupanen, S., Gylfe, A. E., Hänninen, U. A., Cajuso, T., Tanskanen, T. J., Kondelin, J., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.034 · Cited by 110
“Such considerations have not been addressed in previous studies of the relationship between PUFAs and prostate cancer [31] or between branched-chain amino acids and diabetes [32].”
BackgroundAmino acid metabolism in kidney health and disease
Knol, M., Wulfmeyer, V. C., Müller, R., & Rinschen, M. M. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00872-8 · Cited by 124
“In a prospective analysis of the Framingham Heart Study, BCAAs were associated with insulin resistance and the development of T2DM 107 — a finding that has been replicated in other cohorts 108,109 .”
InfluentialYang, Q., Lin, S. L., Kwok, M. K., Leung, G. M., & Schooling, C. M. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy096 · Cited by 107
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
“However, increased SCFA consumption may alleviate the hyperglycemic responses that are occurring in obese and type 2 diabetics, characterized by elevated amino-acid concentrations [154].”
BackgroundMansoori, S., Ho, M. Y., Ng, K. K., & Cheng, K. K. Y. (2024) · Obesity Reviews · doi:10.1111/obr.13856 · Cited by 122
“36 40 On the other hand, the genetic variants linked with insulin resistance are strongly associated with higher circulating BCAA levels in humans.”
Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes
Ottosson, F. A., Smith, E., Melander, O., & Fernandez, C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00546 · Cited by 107
Cuomo, P., Capparelli, R., Iannelli, A., & Iannelli, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084325 · Cited by 110
“A Mendelian randomization study concluded that BCAAs cause IR [31]; another study reached a contradictory conclusion, namely, that IR causes high levels of BCAAs [32].”
BackgroundPrecision medicine in diabetes: an opportunity for clinical translation
Merino, J., & Florez, J. C. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13588 · Cited by 94
Connelly, M. A., Wolak, J. E., & Dullaart, R. P. F. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0145 · Cited by 86
Branched-Chain Amino Acids and Insulin Resistance, from Protein Supply to Diet-Induced Obesity
Bandt, J. P. D., Coumoul, X., & Barouki, R. (2022) · Nutrients · doi:10.3390/nu15010068 · Cited by 99
“[52] metaanalyzed the data from five prospective studies (with a total of 1.”
BackgroundInfluentialTobias, D. K., Clish, C. B., Mora, S., Li, J., Liang, L., Hu, F. B., Manson, J. E., & Zhang, C. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.285841 · Cited by 85
Shu, L., Chan, K. H. K., Zhang, G., Huan, T., Kurt, Z., Zhao, Y., Codoni, V., Trégouët, D., Yang, J. J., Wilson, J. G., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007040 · Cited by 85
“Our finding on BCAA is consistent with recent work relating serum levels of BCAA to risk of CVD and T2D in large prospective cohorts [42, 43], although whether BCAA is a “pathophenotype” or strong pathogenic factor has been debated [28, 44].”
ResultDistinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus
Gu, X., Dubayee, M. A., Alshahrani, A. S., Masood, A., Benabdelkamel, H., Zhra, M., Li, L., Rahman, A. M. A., & Aljada, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.609806 · Cited by 84
“Association with the incidence of T2DM and four essential (Ile, Leu, Trp, and Val) and two non-essential (Gln and Tyr) amino acids was also reported while the accumulation of Gln and Gly was associated with T2DM lower risk (Lu et al., 2019).”
BackgroundBrown Adipose Tissue Heterogeneity, Energy Metabolism, and Beyond
Shinde, A. B., Song, A., & Wang, Q. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651763 · Cited by 90
Metabolomics: The Stethoscope for the Twenty-First Century
Ashrafian, H., Sounderajah, V., Glen, R. C., Ebbels, T. M. D., Blaise, B. J., Kalra, D., Kultima, K., Spjuth, O., Tenori, L., Salek, R. M., et al. (2020) · Medical Principles and Practice · doi:10.1159/000513545 · Cited by 79
Branched-chain amino acids and Alzheimer’s disease: a Mendelian randomization analysis
Larsson, S. C., & Markus, H. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12931-1 · Cited by 72
Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes
Mardinoğlu, A., Gogg, S., Lotta, L. A., Stančáková, A., Nerstedt, A., Borén, J., Blüher, M., Ferrannini, E., Langenberg, C., Wareham, N. J., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.008 · Cited by 77
“In EPIC-Norfolk, BCAA-related metabolites were measured using an untargeted UPLC-MS/MS platform (DiscoveryHD4® platform - Metabolon Inc.) in citrated plasma samples collected at baseline as previously described (Lotta et al., 2016).”
Self-citationIGF-1 and cardiometabolic diseases: a Mendelian randomisation study
Larsson, S. C., Michaëlsson, K., & Burgess, S. (2020) · Diabetologia · doi:10.1007/s00125-020-05190-9 · Cited by 76
Self-citationPlacental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches
Hebert, J. F., & Myatt, L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165967 · Cited by 81
“Mitochondrial function and trophoblast-specific roles Mitochondria are complex, double-membraned organelles that generate adenosine triphosphate (ATP) using oxidative phosphorylation [51].”
BackgroundInfluentialTrautman, M. E., Richardson, N. E., & Lamming, D. W. (2022) · Aging Cell · doi:10.1111/acel.13626 · Cited by 70
“One meta- analysis found several single nucleotide polymorphisms (SNPs) in genomic regions of BCAA catabolism and connected these SNPs to elevated BCAAs and insulin resistance (Lotta et al., 2016).”
BackgroundCorrie, L., Awasthi, A., Kaur, J., Vishwas, S., Gulati, M., Kaur, I. P., Gupta, G., Kommineni, N., Dua, K., & Singh, S. K. (2023) · Pharmaceuticals · doi:10.3390/ph16020197 · Cited by 85
“Another study revealed that the more BCAAs the individuals consumed, the greater is their risk of developing type 2 diabetes [126].”
BackgroundShi, L. S., Brunius, C. F., Lehtonen, M., Auriola, S. O. K., Bergdahl, I. A., Rolandsson, O., Hanhineva, K., & Landberg, R. (2018) · Diabetologia · doi:10.1007/s00125-017-4521-y · Cited by 80
“HOMA-IR and HOMA-%B were computed using the HOMA calculator (www.dtu.ox.ac.uk; accessed 1 June 2017).”
InfluentialRole of dietary histidine in the prevention of obesity and metabolic syndrome
DiNicolantonio, J. J., McCarty, M. F., & O’Keefe, J. H. (2018) · Open Heart · doi:10.1136/openhrt-2017-000676 · Cited by 81
“Indeed, a recent Mendelian randomisation analysis concludes that elevated plasma levels of BCAA are likely to be true mediators of increased risk for type 2 diabetes.(45) This phenomenon would be analogous to the well-known ability of high plasma levels of neutral amino acids to impede brain serotonin production from…”
BackgroundRoles of Gut Microbial Metabolites in Diabetic Kidney Disease
Fang, Q., Liu, N., Zheng, B., Guo, F., Zeng, X., Huang, X., & Ouyang, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.636175 · Cited by 75
Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality
Ottosson, F. A., Smith, E., Ericson, U., Brunkwall, L., Orho‐Melander, M., Somma, S. D., Antonini, P., Nilsson, P. M., Fernandez, C., & Melander, O. (2022) · Diabetes Care · doi:10.2337/dc21-2402 · Cited by 78
Approaches and advances in the genetic causes of autoimmune disease and their implications
Inshaw, J. R. J., Cutler, A. J., Burren, O. S., Stefana, M. I., & Todd, J. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0129-8 · Cited by 70
Mendelian randomization as a tool for causal inference in human nutrition and metabolism
Larsson, S. C. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000721 · Cited by 77
Yang, S. J., Kwak, S., Jo, G., Song, T., & Shin, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26320-9 · Cited by 71
Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young Individuals
Tahir, U. A., & Gerszten, R. E. (2023) · Circulation Research · doi:10.1161/circresaha.123.322000 · Cited by 82
Kadakia, R., Nodzenski, M., Talbot, O., Kuang, A., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Ilkayeva, O., O’Neal, S., Lowe, L. P., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4781-1 · Cited by 64
“Genetic studies have also demonstrated that SNPs associated with elevated BCAA are also strongly associated with type 2 diabetes risk [30, 32].”
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases
Yin, X., Chen, Y., Ruze, R., Xu, R., Song, J., Wang, C., & Xu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01178-6 · Cited by 77
Blair, M. C., Neinast, M. D., Jang, C., Chu, Q., Jung, J. W., Axsom, J., Bornstein, M. R., Thorsheim, C. L., Li, K., Hoshino, A., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00794-y · Cited by 69
Vanweert, F., de Ligt, M., Hoeks, J., Hesselink, M. K. C., Schrauwen, P., & Phielix, E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa751 · Cited by 65
Hamaya, R., Mora, S., Lawler, P. R., Cook, N. R., Ridker, P. M., Buring, J. E., Lee, I.-M. M., Manson, J. E., & Tobias, D. K. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003330 · Cited by 66
Slieker, R. C., Donnelly, L. A., Fitipaldi, H., Bouland, G. A., Giordano, G. N., Åkerlund, M., Gerl, M. J., Ahlqvist, E., Ali, A., Dragan, I., et al. (2021) · Diabetes · doi:10.2337/db20-1281 · Cited by 69
“16 be risk factors for developing incident type 2 diabetes in observational studies; their causal role has also been suggested.(33) Both BCAAs and DAG inhibit insulin receptor substrate 1 (IRS1).”
BackgroundAmino acid transporters as modulators of glucose homeostasis
Bröer, S. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.11.004 · Cited by 65
Zhu, H., Bai, M., Xie, X., Wang, J., Weng, C., Dai, H., Chen, J., Han, F., & Lin, W. (2022) · Nutrients · doi:10.3390/nu14163345 · Cited by 59
Bishop, C. A., Schulze, M. B., Klaus, S., & Weitkunat, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000195r · Cited by 62
Cohain, A. T., Barrington, W. T., Jordan, D. M., Beckmann, N. D., Argmann, C., Houten, S. M., Charney, A. W., Ermel, R., Sukhavasi, K., Franzén, O., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20750-8 · Cited by 65
BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
Guo, X., Zhu, Y., Guo, L., Qi, Y., Liu, X., Wang, J., Zhang, J., Cui, L., Shi, Y., Wang, Q., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317450 · Cited by 62
Huang, J., Weinstein, S. J., Moore, S. C., Derkach, A., Hua, X., Liao, L. M., Gu, F., Mondul, A. M., Sampson, J. N., & Albanes, D. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy017 · Cited by 54
Altered branched chain amino acid metabolism: toward a unifying cardiometabolic hypothesis
Tobias, D. K., Mora, S., Verma, S., & Lawler, P. R. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000552 · Cited by 56
Ferguson, D., Eichler, S. J., Yiew, N. K. H., Colca, J. R., Cho, K., Patti, G. J., Shew, T. M., Lutkewitte, A. J., Mukherjee, S. K., McCommis, K. S., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101694 · Cited by 60
“On the other hand, genome-wide association studies have linked genetic variations in enzymes that control BCAA metabolism [18,19,38], especially PPM1K [19], to plasma BCAA levels and insulin resistance and dietary restriction of BCAA in ZDF rats lowers plasma BCAAs and improves insulin sensitivity [17], suggesting tha…”
BackgroundResultRecent advances in the managements of type 2 diabetes mellitus and natural hypoglycemic substances
Ning, C., Jiao, Y., Wang, J., Li, W., Zhou, J., Lee, Y., Ma, D., Leung, C., Zhu, R., & Wang, H. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.04.004 · Cited by 66
Tong, T. Y. N., Koulman, A., Griffin, J. L., Wareham, N. J., Forouhi, N. G., & Imamura, F. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz263 · Cited by 56
“The Fenland Study is a general population cohort which recruited 12,435 participants via general practices from 3 centers (Cambridge, Ely, Wisbech) in Cambridgeshire, United Kingdom (12, 24).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., Marney, L., Koulman, A., Karoly, E. D., Forouhi, N. G., Sjögren, R. J. O., Näslund, E., Zierath, J. R., Krook, A., Savage, D. B., Griffin, J. L., Chaturvedi, N., Hingorani, A. D., Khaw, K.-T., Barroso, I., McCarthy, M. I., O’Rahilly, S., Wareham, N. J., & Langenberg, C.
- Affiliations
- University of Cambridge (GB)
- University College London (GB)
- MRC Elsie Widdowson Laboratory (GB)
- Metabolon (United States) (US)
- Karolinska Institutet (SE)
- Danderyds sjukhus (SE)
- Centre for Human Genetics (GB)
- Corresponding author
- Wareham, Nicholas J.
- Langenberg, Claudia
- ORCID
- Lotta, Luca A.
- Scott, Robert A.
- Sharp, Stephen J.
- Burgess, Stephen
- Luan, Jian’an
- Tillin, Therese
- Schmidt, Amand F.
- Imamura, Fumiaki
- Perry, John R. B.
- Marney, Luke
- Koulman, Albert
- Karoly, Edward D.
- Forouhi, Nita G.
- Sjögren, Rasmus J. O.
- Näslund, Erik
- Zierath, Juleen R.
- Krook, Anna
- Savage, David B.
- Griffin, Julian L.
- Chaturvedi, Nishi
- Hingorani, Aroon D.
- Khaw, Kay-Tee
- Barroso, Inês
- McCarthy, Mark I.
- O’Rahilly, Stephen
- Wareham, Nicholas J.
- Langenberg, Claudia
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-29
- Volume
- 13
- Issue
- 11
- Pages
- e1002179
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5127513
- OpenAlex
- W2559236589
- Cited by
- 417
- References
- 73
- Citations by year
- 2026: 20 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 49 · 2021: 61 · 2020: 50 · 2019: 31 · 2018: 52 · 2017: 21 · 2016: 1
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_12015/1, MC_PC_13046, MC_PC_13048 and MR/L00002/1 - MRC Epidemiology Unit, MC_UP_A090_1006 - MRC Human Nutrition Research, SABRE Study)
- National Institute for Health Research (Biomedical Research Centre—MRC Epidemiology Unit)
- EMIF (n° 115372)
- Cambridge Lipidomics Biomarker Research Initiative (G0800783 - MRC Epidemiology Unit and MRC Human Nutrition Research)
- Diabetes UK (SABRE Study)
- British Heart Foundation (GB) (SABRE Study)
- Wellcome Trust (GB) (WT082464 - SABRE Study, SP/07/001/23603 - SABRE Study)
- Diabetes UK (GB) (13/0004774 - SABRE Study)
- Vetenskapsrådet (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Novo Nordisk Foundation (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Diabetes Wellness (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Wellcome Trust (107064, 090532, 098381, WT098051)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- branched-chain amino acids, type 2 diabetes, branched-chain amino acid metabolism, PPM1K, branched-chain ketoacid dehydrogenase, genetic susceptibility, causal inference, isoleucine, leucine, valine, circulating amino acids, polygenic risk score, heritability, pleiotropy, mitochondrial metabolism, metabolite accumulation
- MeSH terms
- Adult, Aged, Amino Acids, Branched-Chain, Diabetes Mellitus, Type 2, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Sweden, Genetic Predisposition to Disease, Genome-Wide Association Study, Young Adult, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.